Acute Myeloid Leukemia: Evidence-Based Guidance on Current Paradigms and New Therapeutic Approaches
The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with AML.
Monthly Oncology Tumor Boards: Updates in the Management of Pancreatic Cancer
Continued education regarding the management of pancreatic cancer is required to bridge the gap in cancer care and improve outcomes in the patient population.
NCCN Pharmacy Updates: The Evolving Landscape of Maintenance Therapy for Ovarian Cancer
This webinar will discuss key concepts in maintenance therapy for ovarian cancer, review clinical efficacy and safety data on potential treatment options and identify and address special considerations for monitoring and patient/caregiver education.
Monthly Oncology Tumor Boards: Updates in Management of Renal Cell Carcinoma
Clinicians may find it difficult to determine which single- or multi-agent therapies are most effective for patients with different kidney cancer histologies and risk groups. The NCCN Categories of Preference and Categories of Evidence and Consensus help to stratify the most effective treatment regimens by histology and risk status.
NCCN Pharmacy Updates: Infection Concerns with Emerging Immune-targeted Treatments in Immunocompromised Patients with Cancer
Although the toxicity profiles of the newer molecularly targeted drugs are less focused on blood cells than those of traditional cytotoxic therapies, there are still infectious risks; safety and efficacy can only be guaranteed by multidisciplinary teams that have therapeutic expertise in the pharmacology of oral anti-cancer therapy.
Monthly Oncology Tumor Boards: Optimal Multidisciplinary Management of Advanced Esophageal Cancer
Clinicians must consider disease stage, histology, biomarker expression and patient performance status to make decisions regarding optimal care of patients with esophageal cancer.
Monthly Oncology Tumor Boards: Advances in the Management of Gastrointestinal Stromal Tumors (GIST) and Other Soft Tissue Sarcomas
Continued education for oncology care providers is necessary to convey updates in the management of STS and improve patient outcomes.
Exploring an Expanding AML Therapeutic Armamentarium: Expert Guidance to Optimize Outcomes
The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with AML.
Combination Therapy in RCC: Expert Guidance to Individualize Treatment and Improve Outcomes
The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with RCC.
Guideline Updates and Real-World Experiences in CLL: State-of-the-Art Evidence and Next Questions
The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with CLL/SLL.

Pages

Subscribe to RSS - Live Webinar